132 related articles for article (PubMed ID: 10082895)
1. Expression and localisation of CYP2D enzymes in rat basal ganglia.
Riedl AG; Watts PM; Edwards RJ; Schulz-Utermoehl T; Boobis AR; Jenner P; Marsden CD
Brain Res; 1999 Mar; 822(1-2):175-91. PubMed ID: 10082895
[TBL] [Abstract][Full Text] [Related]
2. Expression and distribution of CYP2C enzymes in rat basal ganglia.
Riedl AG; Watts PM; Douek DC; Edwards RJ; Boobis AR; Rose S; Jenner P
Synapse; 2000 Dec; 38(4):392-402. PubMed ID: 11044886
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression.
Schulz-Utermoehl T; Bennett AJ; Ellis SW; Tucker GT; Boobis AR; Edwards RJ
Pharmacogenetics; 1999 Jun; 9(3):357-66. PubMed ID: 10471068
[TBL] [Abstract][Full Text] [Related]
4. Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase.
Watts PM; Riedl AG; Douek DC; Edwards RJ; Boobis AR; Jenner P; Marsden CD
Neuroscience; 1998 Sep; 86(2):511-9. PubMed ID: 9881865
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of cytochrome P450 enzymes in cultured and intact foetal rat ventral mesencephalon.
Gilbert EA; Edwards RJ; Boobis AR; Rose S; Jenner P
J Neural Transm (Vienna); 2003 Oct; 110(10):1091-101. PubMed ID: 14523622
[TBL] [Abstract][Full Text] [Related]
6. Selective localisation of P450 enzymes and NADPH-P450 oxidoreductase in rat basal ganglia using anti-peptide antisera.
Riedl AG; Watts PM; Edwards RJ; Boobis AR; Jenner P; Marsden CD
Brain Res; 1996 Dec; 743(1-2):324-8. PubMed ID: 9017262
[TBL] [Abstract][Full Text] [Related]
7. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study.
Bromek E; Haduch A; Daniel WA
Eur J Pharmacol; 2010 Jan; 626(2-3):171-8. PubMed ID: 19818757
[TBL] [Abstract][Full Text] [Related]
8. The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia.
Danek PJ; Daniel WA
Cells; 2022 Nov; 11(21):. PubMed ID: 36359909
[TBL] [Abstract][Full Text] [Related]
9. Regional distribution of cytochrome P450 2D1 in the rat central nervous system.
Norris PJ; Hardwick JP; Emson PC
J Comp Neurol; 1996 Mar; 366(2):244-58. PubMed ID: 8698885
[TBL] [Abstract][Full Text] [Related]
10. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity.
Wan J; Imaoka S; Chow T; Hiroi T; Yabusaki Y; Funae Y
Arch Biochem Biophys; 1997 Dec; 348(2):383-90. PubMed ID: 9434752
[TBL] [Abstract][Full Text] [Related]
11. Catalytic specificity of CYP2D isoforms in rat and human.
Hiroi T; Chow T; Imaoka S; Funae Y
Drug Metab Dispos; 2002 Sep; 30(9):970-6. PubMed ID: 12167561
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms.
Danek PJ; Daniel WA
Cells; 2021 Dec; 10(12):. PubMed ID: 34943983
[No Abstract] [Full Text] [Related]
13. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.
Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP
Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487
[TBL] [Abstract][Full Text] [Related]
14. Intralaminar thalamic nuclei lesions: widespread impact on dopamine denervation-mediated cellular defects in the rat basal ganglia.
Bacci JJ; Kachidian P; Kerkerian-Le Goff L; Salin P
J Neuropathol Exp Neurol; 2004 Jan; 63(1):20-31. PubMed ID: 14748558
[TBL] [Abstract][Full Text] [Related]
15. Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver.
Chow T; Imaoka S; Hiroi T; Funae Y
Drug Metab Dispos; 1999 Feb; 27(2):188-92. PubMed ID: 9929501
[TBL] [Abstract][Full Text] [Related]
16. Importance of CYP2D3 in polymorphism of diazepam p-hydroxylation in rats.
Sakai N; Saito K; Kim HS; Kazusaka A; Ishizuka M; Funae Y; Fujita S
Drug Metab Dispos; 2005 Nov; 33(11):1657-60. PubMed ID: 16081673
[TBL] [Abstract][Full Text] [Related]
17. Regional and cellular distribution of CYP2D subfamily members in rat brain.
Miksys S; Rao Y; Sellers EM; Kwan M; Mendis D; Tyndale RF
Xenobiotica; 2000 Jun; 30(6):547-64. PubMed ID: 10923858
[TBL] [Abstract][Full Text] [Related]
18. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.
Rolland AS; Herrero MT; Garcia-Martinez V; Ruberg M; Hirsch EC; François C
Brain; 2007 Jan; 130(Pt 1):265-75. PubMed ID: 17148469
[TBL] [Abstract][Full Text] [Related]
19. The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain.
Haduch A; Bromek E; Daniel WA
Eur J Pharmacol; 2011 Jan; 651(1-3):51-8. PubMed ID: 21115002
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
Czarnecka A; Lenda T; Domin H; Konieczny J; Smiałowska M; Lorenc-Koci E
Brain Res; 2013 Dec; 1541():92-105. PubMed ID: 24129225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]